4-((1-Methyl-1H-tetrazol-5-yl)thio)-2-phenylquinazoline
98%
- Product Code: 192272
CAS:
851168-98-4
| Molecular Weight: | 320.37 g./mol | Molecular Formula: | C₁₆H₁₂N₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, Sealed, Inert Gas |
Product Description:
Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in anticancer drug development. It exhibits potential in targeting epidermal growth factor receptor (EGFR) pathways, making it valuable in pharmaceutical research for lung and breast cancer treatments. Its structure allows for modification to enhance selectivity and potency against tumor cells. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 G | 10-20 days | ฿26,050.00 |
+
-
|
| 0.250 G | 10-20 days | ฿44,280.00 |
+
-
|
4-((1-Methyl-1H-tetrazol-5-yl)thio)-2-phenylquinazoline
Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in anticancer drug development. It exhibits potential in targeting epidermal growth factor receptor (EGFR) pathways, making it valuable in pharmaceutical research for lung and breast cancer treatments. Its structure allows for modification to enhance selectivity and potency against tumor cells. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :